About Generis Farmaceutica
Generis Farmaceutica is a Healthcare company based in Amadora (Portugal) founded in 2002, and was acquired by Aurobindo Pharma in January 2017. Generic drugs for cardiovascular, neurological, and pain disorders are manufactured. Generis Farmaceutica offers products and services including Generic Medicines for Ambulatory Use and Generic Medicines for Hospitals. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is GENERIS Farmacêutica, S.A.
Company details
Generis Farmaceutica was established in 2002 in Amadora, Portugal, within the pharmaceutical sector. Operations center on the production of generic medications, primarily targeting cardiovascular diseases, neurological disorders, and pain management. Additional categories include antihistamines, anti-infectives, and treatments for gastrointestinal, genitourinary, respiratory, dermatological, and diabetic conditions. The companys activities remain focused on these therapeutic areas to support healthcare needs.
- Headquarters Amadora, Portugal
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website generis.pt
- Social LinkedIn Facebook YouTube
- Acquired by Aurobindo Pharma (Jan 2017)
- Legal Name Generis Farmacêutica, S.A.
- InvestorsAurobindo Pharma
& 1 more
- Acquired byAurobindo Pharma
(Jan 2017)
Products & Services of Generis Farmaceutica
Generis Farmaceutica offers a comprehensive portfolio of products and services, including Generic Medicines for Ambulatory Use and Generic Medicines for Hospitals.
Generic medicines are produced and supplied for outpatient treatment in the market
Generic medicines are provided as part of the largest portfolio for hospital use in Portugal
Funding Insights of Generis Farmaceutica
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Generis Farmaceutica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2009 | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Generis Farmaceutica
Generis Farmaceutica has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Aurobindo Pharma and Magnum Industrial Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A leading private equity firm focused on Iberian markets is operated. | 2006 | magnumpartners.com | Madrid, Spain | |
Generic biocatalytic solutions are provided for pharmaceutical applications. | 1986 | aurobindo.com | Hyderabad, India |
Investor details for Generis Farmaceutica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Generis Farmaceutica
30 people are tracked at Generis Farmaceutica (9 in leadership, 21 in team).
| Name | Role | Group |
|---|---|---|
Maria Manuel Serrano | CFO | Leadership |
Luís Abrantes | CEO | Leadership |
Diogo Fernandes | Commercial Director - Retail Business Unit | Leadership |
Ana Cidra | Director Of Quality, Regulatory Affairs & Market Access | Leadership |
João Lucas Silva | Head Of Information Technology | Leadership |
Maria Madalena Rabaça | HR Business Partner | Leadership |
Delia Gonçalves | Human Resources Director | Leadership |
Roberto Fonte | Export Director | Leadership |
Carlos Martins | Head Of Industrial & Operation Unit | Leadership |
Pedro Almeida | Environment, Health, Safety And Sustainability Manager | Team |
Liliana Reis | Marketing Manager | Team |
Sandra Lucas | Environment, Health And Safety Manager | Team |
Nuno Jorge | National Business Unit Manager | Team |
Bruna F. | Supervisora | Team |
Vera Santos | Area Sales Manager | Team |
Sílvia Raimundo | Controlling And Reporting Manager | Team |
Alexandra Domingos | Quality Assurance Manager | Team |
Tânia Silva | Regulatory Affairs Senior Technician | Pre-ma & Market Access Projects | Team |
Filipa Rodrigues | CMC & Post-ma Local Projects Regulatory Affairs Team Leader | Team |
Filipa Ventura Pinto | Regulatory Affairs Manager | Team |
10 more people are available in the full profile.
Complete people profiles for Generis Farmaceutica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Generis Farmaceutica
3 dated milestones of Generis Farmaceutica across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Generis Farmaceutica is founded.
- Funding First funding round.
- Exit Acquired by Aurobindo Pharma.
Web traffic of Generis Farmaceutica
The website of Generis Farmaceutica (generis.pt) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 36.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Generis Farmaceutica
Complete news archive for Generis Farmaceutica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Generis Farmaceutica
Generis Farmaceutica was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Generis Farmaceutica is headquartered in Amadora, Portugal.
Generis Farmaceutica was established in 2002 in Amadora, Portugal, within the pharmaceutical sector. Operations center on the production of generic medications, primarily targeting cardiovascular diseases, neurological disorders, and pain management. Additional categories include antihistamines, anti-infectives, and treatments for gastrointestinal, genitourinary, respiratory, dermatological, and diabetic conditions. The companys activities remain focused on these therapeutic areas to support healthcare needs.
Generis Farmaceutica offers Generic Medicines for Ambulatory Use and Generic Medicines for Hospitals.
Generis Farmaceutica has 2 investors. Key investors include Aurobindo Pharma, and Magnum Industrial Partners.
Generis Farmaceutica operates through Generis Farmacêutica, S.A..
Yes. Generis Farmaceutica was acquired by Aurobindo Pharma in January 2017.